Page 10 - GB-RI-PierreFabre-Complet-INTERACTIF

08 INTEGRATED ANNUAL REPORT 2021 - PIERRE FABRE 86% Share of employees subscribed to the Ruscus shareholder plan in 2020 (5,941 subscribers in 10 countries) The Foundation and the company’s employees: the group’s only shareholders The Pierre Fabre Group has a governance structure that is unique in France, and guarantees its independence and long-term vision: the Pierre Fabre Foundation and the company’s employees are its only shareholders. 5.75% TREASURY STOCK 8.25% EMPLOYEE SHAREHOLDING 86% PIERRE FABRE FOUNDATION Bringing together and involving employees Employees are the Pierre Fabre group’s second largest shareholder group. As of the end of 2020, they owned 8.25% of the company's capital. Since 2005 and the introduction of this employee stock ownership plan, the rate of subscription to the plan has been consistent, which is a sign of confidence in and loyalty to the Group, and this despite the health and economic crisis of 2020. The Ruscus employee shareholding plan, which has gradually been extended to the Group’s subsidiaries, makes it possible to closely link the employees with the company’s performance, in keeping with the wishes of the Group’s founder. In 2021, the Czech Republic will become the 12th subsidiary to have access to it. A Foundation as a majority shareholder Recognized as a French “public interest” organization, the Pierre Fabre Foundation holds 86% of shares of Pierre Fabre SA. As the Foundation is focused on its public interest mission, it delegates supervision of the Group's management to Pierre Fabre Participations. The Group's management appoints the company’s key leaders in keeping with the values passed down from its founder and his passion: ensuring the Group's independence and its sustainability, and pursuing the development of its two long-standing activities, dermo-cosmetics and medical. This is a long-term vision that should be based on creating sustained value while protecting the company’s local presence. PIERRE FABRE SHAREHOLDING A public interest mission to support those who need it most For more than twenty years, the Pierre Fabre Foundation has been working with communities in developing countries in order to improve access to health care and, more specifically, to commonly used drugs. Its key areas of action and research include training of specialists in pharmaceuticals and dermatology and combating sickle-cell disease, the most prevalent genetic disease worldwide and the 4th leading pandemic in Africa. Despite the health crisis, the Foundation has upheld its commitment, in particular in Bangui (Central African Republic), with the opening of a dedicated center for victims of sexual violence that will be able to receive about 3,240 patients. Faced with the COVID-19 global pandemic, the Pierre Fabre Foundation has supported its partners in developing countries by providing them with hydroalcoholic gel as well as FFP2 masks, an action that, for the first time, has been extended to France. Lastly, in October 2020, it held its 5th eHealth conference in developing countries, dedicated to “The Role of Information and Communication Technologies in fighting pandemics.” 3,000 internet users, from around twenty countries, took part.